• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Republican congressman will end monthslong absence from DC after missing 135 roll call votes

by June 19, 2026
written by June 19, 2026

After more than 100 days away from Capitol Hill, Rep. Tom Kean Jr., R-N.J., is set to return to Washington, D.C., in the coming weeks.

Kean, 57, will be present for votes during the June 30 session, a spokesperson for the congressman confirmed to Fox News Digital. The two-term New Jersey lawmaker has been sidelined for months with a personal health issue and has yet to disclose the nature of the ailment. 

Kean has pledged to be transparent about his illness once he is back in Washington.

The New Jersey Globe first reported the timing of Kean’s expected return. He previously told the outlet his medical issue did not affect his cognitive health and will not have any chronic complications that could impair his ability to seek a third House term.

HOUSE REPUBLICAN MISSES ANOTHER WEEK OF VOTES AS HEALTH ABSENCE STRAINS THIN MAJORITY

The embattled lawmaker has not been seen in public or cast a vote on the House floor since early March, amounting to 135 missed roll call votes, according to GovTrack.

Kean’s office has still continued to introduce legislation and post on social media. 

The New Jersey Republican’s expected return to Washington ahead of November’s midterm elections will be relatively short-lived. With just over 30 legislative days remaining, lawmakers are scheduled to spend nearly all of August and October back home campaigning for re-election. 

DEMS PICK CHALLENGER FOR GOP CONGRESSMAN WHO VANISHED FROM PUBLIC VIEW AMID HEALTH MYSTERY

Thursday’s announcement comes as Kean is facing a significant reelection challenge from former Navy helicopter pilot Rebecca Bennett in one of the country’s most competitive House battleground districts.

Bennett, who is expected to lean into her national security background on the campaign trail, defeated several Democrat primary challengers in May to advance to the general election.

She has largely refrained from criticizing Kean during his absence but said he must be transparent with voters about his health issue.

Kean, who has the endorsement of President Donald Trump, ran unopposed for the GOP nomination, but his future in Congress remains unclear amid his absence and health concerns. 

The nonpartisan Cook Political Report rates the New Jersey contest in the suburban swing seat as a “toss-up.”

<!–>

–>

0 comment
0
FacebookTwitterPinterestEmail

previous post
Cathie Wood buys more Tesla, cuts Roku as ARK doubles down on AI
next post
Walz approval rating craters to lowest level ever and trails Trump amid massive fraud scandal: ‘Tired of it’

related articles

Blue state mayor arrested for fraud sparks uproar...

August 18, 2026

Socialists accused of ‘motor mouth’ rhetoric as longtime...

August 18, 2026

Massive risk in South China Sea exposed after...

August 18, 2026

White House tears into Ossoff with brutal takedown...

August 18, 2026

Longtime GOP aide defects to Dem rising star...

August 18, 2026

Minnesota ‘outstanding refugee’ honoree accused in fraud scheme...

August 18, 2026

Corporation targeted by Brandon Gill digs in on...

August 18, 2026

WATCH: Letitia James told ‘do her f—ing job’...

August 18, 2026

Neonatologist sounds alarm over Massachusetts abortion law allowing...

August 18, 2026

Trump endorses replacement GOP nominee Jennifer Balkcom after...

August 18, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump admin bypasses Tehran’s isolation campaign to reach Iranians directly

    June 4, 2026
  • Micron stock jumps as AI memory boom fuels analyst price target hikes

    June 11, 2026
  • Viasat stock jumps as Space Force wins fuel bullish analyst outlook

    June 30, 2026
  • Rocket Lab stock analysis: megaphone forms as experts remain optimistic

    July 6, 2026
  • Trump admin axes ‘Green New Scam’ appliance rules as Europe bakes in brutal heat

    July 2, 2026

Popular Posts

  • 1

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 2

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 3

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 4

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (465)
  • Investing (944)
  • Stock (63)

Latest Posts

  • Top FTSE 100 dividend stocks to buy if you want to retire on passive income

    June 16, 2026
  • GOP rift grows as Thune hits brakes on Trump’s election bill to avert shutdown

    July 24, 2026
  • AST SpaceMobile stock rises as BlueBird launch, Rakuten JV plans emerge

    June 23, 2026

Recent Posts

  • Socialists launch radical platform to abolish the US Senate in bid to fundamentally transform America

    July 10, 2026
  • Spencer Pratt’s runner-up edge over Democrat Raman down to 1%, few thousand ballots

    June 7, 2026
  • Celestica stock analysis: Will the sell-off continue?

    June 19, 2026

Editor’s Pick

  • Why a hawkish Fed isn’t scaring Wall Street

    June 20, 2026
  • Top FTSE 100 dividend stocks to buy if you want to retire on passive income

    June 16, 2026
  • Dow futures plunge 360 points: 5 things to know before Wall Street opens

    July 17, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock